Wave Life Sciences Ltd.WVENASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-12.54%
↓ 113% below average
Average (39q)
97.36%
Historical baseline
Range
High:1212.07%
Low:-138.98%
Volatility
1387.6%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -12.54% |
| Q2 2025 | -5.19% |
| Q1 2025 | -89.04% |
| Q4 2024 | 1191.04% |
| Q3 2024 | -138.98% |
| Q2 2024 | 57.06% |
| Q1 2024 | -56.85% |
| Q4 2023 | -40.96% |
| Q3 2023 | 122.63% |
| Q2 2023 | 70.98% |
| Q1 2023 | 943.50% |
| Q4 2022 | 334.74% |
| Q3 2022 | -24.00% |
| Q2 2022 | -78.57% |
| Q1 2022 | -0.85% |
| Q4 2021 | -95.15% |
| Q3 2021 | 1212.07% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | 173.59% |
| Q3 2020 | 13.97% |
| Q2 2020 | -27.25% |
| Q1 2020 | 73.37% |
| Q4 2019 | -18.06% |
| Q3 2019 | -61.60% |
| Q2 2019 | 152.08% |
| Q1 2019 | -16.41% |
| Q4 2018 | -19.43% |
| Q3 2018 | -7.91% |
| Q2 2018 | 243.11% |
| Q1 2018 | -15.16% |
| Q4 2017 | 147.93% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 72.45% |
| Q3 2016 | -6.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |
| Q4 2015 | 0.00% |